James McNulty

James McNulty

Director of Finance/CFO presso INHIBITOR THERAPEUTICS, INC.

Patrimonio netto: 76 729 $ in data 31/03/2024

73 anni
Health Technology
Commercial Services
Distribution Services

Profilo

James A.
McNulty
is the founder of Pender, McNulty & Newkirk, which was founded in 1976.
Mr. McNulty is also the founder of McNulty & Co., McNulty, Garcia & Ortiz PA.
.
Mr. McNulty's current job(s) include being the Chief Executive Officer at MyMD Pharmaceuticals (Florida), Inc., Director-Tampa Bay Chapter at Financial Executives International since 2013, Director at Quantum Technology Sciences, Inc. since 2012, Member of The American Institute of Certified Public Accountants, Member of Florida Institute of Certified Public Accountants, Chief Financial Officer, Secretary & Treasurer at Inhibitor Therapeutics, Inc. since 2022, and Chief Financial Officer at Repurposed Therapeutics, Inc.Mr. McNulty's former job(s) include being the Lead Independent Director at CV Sciences, Inc. from 2016 to 2020, Chief Financial Officer at Rock Creek Pharmaceuticals, Inc. from 1998 to 2000, Treasurer & Senior Vice President at BioDelivery Sciences International, Inc. from 2000 to 2014, Chief Financial Officer at CeleXx Corp., Chief Financial Officer at BioVest International, Inc. from 2003 to 2007, Secretary & Treasurer at Accentia Biopharmaceuticals, Inc. from 2002 to 2013, Chief Operating & Financial Officer at American Prescription Providers, Inc. from 2000 to 2002, Chief Financial Officer at TEAMM Pharmaceuticals, Inc., Chief Financial Officer at RetinaPharma Technologies, Inc., Chief Financial Officer at Hopkins Capital Group, and Chief Executive & Financial Officer at Defender Pharmaceuticals, Inc. Mr. McNulty's education history includes an undergraduate degree from the University of South Florida in 1972.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
29/03/2024 1 096 135 ( 0.64% ) 76 729 $ 31/03/2024

Posizioni attive di James McNulty

SocietàPosizioneInizio
INHIBITOR THERAPEUTICS, INC. Director of Finance/CFO 13/12/2022
Chief Executive Officer -
Repurposed Therapeutics, Inc. Director of Finance/CFO -
Corporate Officer/Principal -
Director/Board Member 01/01/2012
Florida Institute of Certified Public Accountants Corporate Officer/Principal -
Corporate Officer/Principal -
Tutte le posizioni attive di James McNulty

Precedenti posizioni note di James McNulty

SocietàPosizioneFine
MIRA PHARMACEUTICALS, INC. Director of Finance/CFO 01/12/2023
CV SCIENCES, INC. Director/Board Member 27/07/2020
░░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░ ░░ ░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░ ░░ ░░░░░░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di James McNulty

Formazione di James McNulty

University of South Florida Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di James McNulty

Relazioni

100 +

Relazioni di 1° grado

23

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa3
CV SCIENCES, INC.

Health Technology

INHIBITOR THERAPEUTICS, INC.

Health Technology

MIRA PHARMACEUTICALS, INC.

Health Technology

Aziende private19

Health Technology

Health Technology

Technology Services

Health Technology

Health Technology

Retail Trade

Commercial Services

Distribution Services

Commercial Services

Florida Institute of Certified Public Accountants

Distribution Services

Pender, McNulty & Newkirk

Commercial Services

McNulty, Garcia & Ortiz PA

Electronic Technology

Finance

Repurposed Therapeutics, Inc.

Health Technology

Defender Pharmaceuticals, Inc.

Vedi le connessioni aziendali